Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125382621 | 12538262 | 1 | I | 2016 | 20160630 | 20160707 | 20160707 | PER | US-CELGENEUS-USA-2016070315 | CELGENE | 0.00 | M | Y | 81.08000 | KG | 20160707 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125382621 | 12538262 | 1 | PS | THALOMID | THALIDOMIDE | 1 | Oral | U | B0028AJ | 20785 | 50 | MG | CAPSULES | ||||||
| 125382621 | 12538262 | 2 | SS | THALOMID | THALIDOMIDE | 1 | Oral | 3.5 MILLIGRAM | U | B0028AJ | 20785 | 100 | MG | CAPSULES | QD | ||||
| 125382621 | 12538262 | 3 | C | VELCADE | BORTEZOMIB | 1 | Unknown | 100 MILLILITER | 0 | 3.5 | MG | UNKNOWN | |||||||
| 125382621 | 12538262 | 4 | C | NOVOLOG | INSULIN ASPART | 1 | Unknown | 4 MILLIGRAM | 0 | 100 | ML | UNKNOWN | |||||||
| 125382621 | 12538262 | 5 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 100 MILLIGRAM | 0 | 4 | MG | UNKNOWN | |||||||
| 125382621 | 12538262 | 6 | C | COENZYME Q10 | UBIDECARENONE | 1 | Oral | 66 | 0 | 100 | MG | CAPSULES | |||||||
| 125382621 | 12538262 | 7 | C | CALCIUM ACETATE. | CALCIUM ACETATE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125382621 | 12538262 | 8 | C | Probiotic | PROBIOTICS NOS | 1 | Unknown | 10B CELL | 0 | UNKNOWN | |||||||||
| 125382621 | 12538262 | 9 | C | PROMETHAZINE VC | PHENYLEPHRINE HYDROCHLORIDEPROMETHAZINE HYDROCHLORIDE | 1 | Unknown | .8 MILLIGRAM | 0 | UNKNOWN | |||||||||
| 125382621 | 12538262 | 10 | C | Rena-Vite | ASCORBIC ACIDBIOTINCALCIUM PANTOTHENATECYANOCOBALAMINFOLIC ACIDNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVINTHIAMINE MONONITRATE | 1 | Oral | 400 MILLIGRAM | 0 | .8 | MG | TABLETS | |||||||
| 125382621 | 12538262 | 11 | C | RENAGEL | SEVELAMER HYDROCHLORIDE | 1 | Oral | .8 MILLIGRAM | 0 | 400 | MG | TABLETS | |||||||
| 125382621 | 12538262 | 12 | C | Nephro-Vite | 2 | Unknown | 0 | .8 | MG | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125382621 | 12538262 | 1 | Plasma cell myeloma |
| 125382621 | 12538262 | 3 | Product used for unknown indication |
| 125382621 | 12538262 | 4 | Product used for unknown indication |
| 125382621 | 12538262 | 5 | Product used for unknown indication |
| 125382621 | 12538262 | 6 | Product used for unknown indication |
| 125382621 | 12538262 | 7 | Product used for unknown indication |
| 125382621 | 12538262 | 8 | Product used for unknown indication |
| 125382621 | 12538262 | 9 | Product used for unknown indication |
| 125382621 | 12538262 | 10 | Product used for unknown indication |
| 125382621 | 12538262 | 11 | Product used for unknown indication |
| 125382621 | 12538262 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125382621 | 12538262 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125382621 | 12538262 | Plasma cell myeloma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125382621 | 12538262 | 1 | 20160428 | 0 | ||
| 125382621 | 12538262 | 2 | 2016 | 0 |